BerGenBio ApS: Financial statements 2025
CVR: 44311747
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BerGenBio ApS (CVR 44311747) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 571,502 and a net result of DKK 15,687. Equity in the 2025 report amounted to DKK 203,099. The solvency ratio was 93%.
- Gross Profit
- DKK 571,502
- Profit/Loss
- DKK 15,687
- Equity
- DKK 203,099
- Total Assets
- DKK 218,360
Official annual report
How creditworthy is BerGenBio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BerGenBio ApS has published its interim report for the period September 19, 2023 – December 31, 2024.
About BerGenBio ApS
BerGenBio ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2023. The company is in liquidation. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Mathas Kristensen. The company is owned by BerGenBio ASA. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 571,502 and a net result of DKK 15,687. Equity in the 2025 report amounted to DKK 203,099.